No association of the -2518 MCP-1 A/G promoter polymorphism with incidence and clinical course of IgA nephropathy

Nephrology Dialysis Transplantation

Volumn 19, Issue 3, 2004, Pages 596-601

  Steinmetz, Oliver M ^a   Panzer, Ulf ^a   Harendza, Sigrid ^a   Mertens, Peter R ^b   Ostendorf, Tammo ^b   Floege, Jürgen ^b   Helmchen, Udo ^a   Stahl, Rolf A K ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

CCL2; Chemokine; IgA nephropathy; Inflammation; MCP 1

Indexed keywords

ADENINE; GENOMIC DNA; GUANINE; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; DISEASE PREDISPOSITION; DNA EXTRACTION; ETHNIC DIFFERENCE; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; INCIDENCE; KAPLAN MEIER METHOD; KIDNEY BIOPSY; MACROPHAGE ACTIVATION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RETROSPECTIVE STUDY; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; SURVIVAL; WILD TYPE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHEMOKINE CCL2; CHILD; DNA; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLOMERULONEPHRITIS, IGA; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; REGULATORY SEQUENCES, NUCLEIC ACID; RETROSPECTIVE STUDIES;

EID: 1342327514     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg577     Document Type: Article

References (21)

1. Donadio JV, Grande JP. Medical progress: IgA nephropathy. New Engl J Med 2002; 347: 738-748
2. Floege J, Feehally J. IgA nephropathy: recent developments. J Am Soc Nephrol 2000; 11: 2395-2403
3. D'Amico G. Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am J Kidney Dis 2000; 36: 227-237
4. Falk MC, Ng G, Zhang GY et al. Infiltration of the kidney by alpha beta and gamma T cells: effects on progression in IgA nephropathy. Kidney Int 1995; 47: 177-185
5. Alexopoulos E, Seron D, Hartley RB, Nolasco F, Cameron JS. The role of the interstitial infiltrates in IgA nephropathy: a study with monoclonal antibodies. Nephrol Dial Transplant 1989; 4: 187-195
6. Li HL, Hancock WW, Hooke DH, Dowling JP, Atkins RC. Mononuclear cell activation and decreased renal function in IgA nephropathy with crescents. Kidney Int 1990; 37: 1552-1556
7. Baggiolini, M. Chemokines and leukocyte traffic. Nature 1998; 392: 565-568
8. Wenzel U, Schneider A, Valente AJ et al. Monocyte chemoattractant protein-1 mediates monocyte/macrophage influx in antithymocyte antibody-induced glomerulonephritis. Kidney Int 1997; 51: 770-776
9. Panzer U, Thaiss F, Zahner G et al. Monocyte chemoattractant protein-1 and osteopontin differentially regulate monocyte recruitment in experimental glomerulonephritis. Kidney Int 2001; 59: 1762-1769
10. Noris M, Bernasconi S, Casiraghi F et al. Monocyte chemoattractant protein-1 is excreted in excessive amounts in the urine of patients with lupus nephritis. Lab Invest 1995; 73: 804-809
11. Rovin BH, Rumancik M, Tan L, Dickerson J. Glomerular expression of monocyte chemoattractant protein-1 in experimental and human glomerulonephritis. Lab Invest 1994; 71: 536-542
12. Rovin BH, Lu L, Saxena R. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 1999; 259: 344-348
13. Toshiaki J, Masaru T, Masayuki S et al. Monocyte chemoattractant protein-1 gene regulatory region polymorphism and serum levels of monocyte chemoattractant protein-1 in Japanese patients with Kawasaki disease. Arthritis Rheum 2001; 44: 2211-2212
14. Aguilar F, González-Escribano MF, Sánchez-Román J, Nunez-Roldán A. MCP-1 promotor polymorphism in Spanish patients with systemic lupus erythematosus. Tissue Antigens 2001; 58: 335-338
15. Szalai C, Duba J, Prohászka Z et al. Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp (a) and MCP-1 -518 G/G genotype in CAD patients. Atherosclerosis 2001; 158: 233-239
16. Szalai C, Kozma GT, Nagy A et al. Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity. J Allergy Clin Immunol 2001; 108: 75-81
17. Bartosik LP, Lajoie G, Sugar L, Cattran DC. Predicting progression in IgA nephropathy. Am J Kidney Dis 2001; 38: 728-735
18. Lu BB, Rutledge BJ, Gu L et al. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein-1 deficient mice. J Exp Med 1998; 187: 601-608
19. Tesch GH, Maifert S, Schwarting A, Rollins BJ, Kelley VR. Monocyte chemoattractant protein-1 dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas (lpr) mice. J Exp Med 1999; 190: 1813-1824
20. Tesch GH, Schwarting A, Kinoshita K, Lan HY, Rollins BJ, Kelley VR. Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis. J Clin Invest 1999; 103: 73-80
21. Saitoh A, Suzuki Y, Takeda M, Kubota K, Itoh K, Tomino Y. Urinary levels of monocyte chemoattractant protein-1 (MCP-1) and disease activity in patients with IgA nephropathy. J Clin Lab Anal 1998; 12: 1-5